cisplatin analogues
Recently Published Documents


TOTAL DOCUMENTS

55
(FIVE YEARS 2)

H-INDEX

15
(FIVE YEARS 1)

Molecules ◽  
2019 ◽  
Vol 24 (15) ◽  
pp. 2739 ◽  
Author(s):  
Dik-Lung Ma ◽  
Chun Wu ◽  
Ke-Jia Wu ◽  
Chung-Hang Leung

Targeting apoptosis is a principal strategy in the design of anticancer drugs. In recent years, non-platinum-based scaffolds have been exploited as viable candidates for the exploitation of anticancer agents with potentially lower toxicity than the widely used cisplatin analogues. This review highlights the latest advances in developing iridium(III) complexes as anticancer agents that act particularly via targeting apoptotic cell death in cancer cells.


BioMetals ◽  
2017 ◽  
Vol 30 (5) ◽  
pp. 733-746 ◽  
Author(s):  
Giarita Ferraro ◽  
Ilaria De Benedictis ◽  
Annamaria Malfitano ◽  
Giancarlo Morelli ◽  
Ettore Novellino ◽  
...  

2017 ◽  
Vol 439 (1-2) ◽  
pp. 19-33 ◽  
Author(s):  
Isidora M. Stojic ◽  
Vladimir I. Zivkovic ◽  
Ivan M. Srejovic ◽  
Tamara R. Nikolic ◽  
Nevena S. Jeremic ◽  
...  

2017 ◽  
Vol 22 (44) ◽  
pp. 6645-6664 ◽  
Author(s):  
Megan Hardie ◽  
Hieronimus Kava ◽  
Vincent Murray
Keyword(s):  

ChemMedChem ◽  
2014 ◽  
Vol 10 (1) ◽  
pp. 183-192 ◽  
Author(s):  
Wilma Neumann ◽  
Brenda C. Crews ◽  
Menyhárt B. Sárosi ◽  
Cristina M. Daniel ◽  
Kebreab Ghebreselasie ◽  
...  

2014 ◽  
Vol 50 (30) ◽  
pp. 3918-3920 ◽  
Author(s):  
Keshab Rijal ◽  
Xun Bao ◽  
Christine S. Chow

Cisplatin analogues containing ligands with altered sizes and charge distributions show different specificity for RNA compared to the parental compound.


Sign in / Sign up

Export Citation Format

Share Document